These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 6438150

  • 1. Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-1 mouse fetus.
    Eluma FO, Sucheston ME, Hayes TG, Paulson RB.
    J Craniofac Genet Dev Biol; 1984; 4(3):191-210. PubMed ID: 6438150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sodium valproate-induced cardiovascular abnormalities in the Jcl:ICR mouse fetus: peak sensitivity of gestational day and dose-dependent effect.
    Sonoda T, Ohdo S, Ohba K, Okishima T, Hayakawa K.
    Teratology; 1993 Aug; 48(2):127-32. PubMed ID: 8211818
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate.
    Turner S, Sucheston ME, De Philip RM, Paulson RB.
    Teratology; 1990 Apr; 41(4):421-42. PubMed ID: 2111044
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Teratogenic effects of vigabatrin in TO mouse fetuses.
    Abdulrazzaq YM, Bastaki SM, Padmanabhan R.
    Teratology; 1997 Mar; 55(3):165-76. PubMed ID: 9181670
    [Abstract] [Full Text] [Related]

  • 12. Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice.
    Afshar M, Moallem SA, Houshang Mohammadpour A, Shiravi A, Majid Jalalian S, Jafar Golalipour M.
    Cutan Ocul Toxicol; 2010 Mar; 29(1):10-5. PubMed ID: 19895254
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fetal anticonvulsant syndrome in rats: dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione and phenobarbital exposure on the structural and functional development of the offspring.
    Vorhees CV.
    J Pharmacol Exp Ther; 1983 Nov; 227(2):274-87. PubMed ID: 6195326
    [Abstract] [Full Text] [Related]

  • 15. Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. I.
    Eibs HG, Spielmann H, Hägele M.
    Teratology; 1982 Feb; 25(1):27-36. PubMed ID: 6461082
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The developmental toxicity of inhaled methanol in the CD-1 mouse, with quantitative dose-response modeling for estimation of benchmark doses.
    Rogers JM, Mole ML, Chernoff N, Barbee BD, Turner CI, Logsdon TR, Kavlock RJ.
    Teratology; 1993 Mar; 47(3):175-88. PubMed ID: 8475461
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.